Skip To Main Content
Tatum Anderson on Muck Rack

Tatum Anderson

Verified
(She/Her)
London
As seen in: International Travel & Health Insurance Journal, BBC, The Guardian, Flipboard, Medscape, Medscape France, Medscape Noticias Médicas, Medscape PT, The Lancet
Covers:  epidemics, pandemics, health systems, health policy, LMICs, UHC, health technologies, post-partum haemorrage, emergency medicine, NCDs, infectious diseases, sexual and reproductive health
Writer. Journalist. PhD candidate. Represented by Catherine Cho @catkcho

Get in touch with Tatum

Contact Tatum, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Tatum Anderson’s Biography

Read Full Bio →

I am a writer and have been for over 25 years. As a global health journalist, I have written for publications including WHO Bulletin, the Lancet, the Guardian, BMJ, BBC News and Nature. I write about the international side to healthcare from maternal mortality to affordable insulin, TB vaccine R&D to US HMOs.

My first novel, Bad Material, was a finalist in the Mslexia Novel Competition 2021, judged by Hilary Mantel, Marianne Tatepo and Jo Unwin. I also won a place on the Hachette Grow Your Sto…

Tatum Anderson’s Journalist Portfolio

Tackling skin lightening’s harms

Tackling skin lightening’s harms

A project in Gabon, Jamaica and Sri Lanka to eliminate mercury in skin-lightening products is highlighting th…

View article →
The tuberculosis vaccine challenge

The tuberculosis vaccine challenge

The development of effective tuberculosis vaccines requires significant advances in knowledge and methods and…

View article →

Articles

TB Vaccine Pipeline Enters Most Promising Phase in Decades

|
By Tatum Anderson Verified
| Medscape Verified
After decades of stalled progress, tuberculosis (TB) vaccine development is gaining momentum, with 18 candidates now in clinical development and several in or approaching late-stage trials. The pipeline includes vaccines designed to prevent TB disease in adolescents and adults, replace Bacillus Calmette-Guérin (BCG) in early-life immunization, and prevent recurrence after TB treatment.
Open in Who Shared Issue with article?

Europe Wants Drug Security, but It Won’t Come Cheap

|
By Tatum Anderson Verified
| Medscape Verified
In the winter of 2022, Europe ran short of one of medicine’s workhorses. Amoxicillin — both on its own and in combination with clavulanic acid — became scarce as seasonal demand for pediatric formulations jumped by 500% and manufacturers could not keep pace. “We had shortages throughout the European Union [EU],” said Monica Dias, PharmD, PhD, head of supply and availability of medicines at the European Medicines Agency (EMA).
Open in Who Shared Issue with article?

Romania Remains Europe’s Measles Hotspot

|
By Tatum Anderson Verified
| Medscape Verified
Romania’s measles outbreak has eased since last year, but the country remains a clear hotspot in the European Union and European Economic Area (EU/EEA), with young children still accounting for a large share of cases and vaccination gaps proving difficult to close. Romania accounted for well over half of all 7655 reported measles cases across 30 EU/EEA countries in 2025, according to recent data from the European Centre for Disease Prevention and Control (ECDC).
Open in Who Shared Issue with article?
See all 61 articles